Heterogeneity of Mild to Moderate Persistent Asthma in Children: Confirmation by Latent Class Analysis and

Anne M Fitzpatrick1, Leonard B Bacharier2, Daniel J Jackson3

  • 1Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, Ga.

Insights

This study identified five distinct subgroups of children with mild to moderate asthma. Allergic sensitization and lung function are key indicators for predicting future asthma exacerbations in pediatric patients.

Area of Science:

  • Pediatric Pulmonology
  • Asthma Research
  • Clinical Phenotyping

Background:

  • Phenotypic characterization of pediatric asthma is limited, hindering prediction of poor outcomes.
  • Identifying at-risk children with asthma is crucial for effective management.

Purpose of the Study:

  • To identify latent classes in children with mild to moderate asthma.
  • To determine if these classes predict future lung function and exacerbation rates.

Main Methods:

  • Latent class analysis of 2593 children (aged 5-18) with mild to moderate asthma.
  • Utilized 19 variables including demographics, symptoms, lung function, and allergic sensitization.
  • Assessed lung function and exacerbation rates at 12-month follow-up.

Main Results:

  • Identified five distinct latent classes with varying features (demographics, asthma control, sensitization, type 2 inflammation, lung function).
  • Exacerbation rates differed across classes, with higher rates in those with airflow limitation.
  • Lung function abnormalities persisted in one class at 12 months.

Conclusions:

  • Pediatric asthma is heterogeneous; latent classes reveal distinct patient subgroups.
  • Allergic sensitization and lung function are valuable for predicting exacerbation risk.
  • Further research is needed to link latent classes to phenotypes for personalized asthma treatment.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.6K